Tag: Emcure Pharmaceuticals Ltd

While India is vaccinating its population with Covishield and Covaxin, country’s first mRNA vaccine developed by Gennova (a subsidiary of Emcure Pharma), is all set to be made available by... Read More

Pune-based vaccine maker Gennova could become the second company in India to receive advance payment from the Union government for manufacturing and stockpiling its Covid-19 vaccine, based on mRNA platform,... Read More

Pune-based Emcure Pharmaceuticals, one of India’s biggest unlisted pharma companies likely to file its draft red herring prospectus (DRHP) with the market regulator SEBI next week for Rs 4,000 crore... Read More

Emcure Pharmaceuticals Ltd. has announced the appointment of four independent directors to strengthen its board. The new additions include Shailesh Ayyangar, former MD Sanofi India; Vijay Gokhale, formerly in Indian Foreign... Read More

Emcure Pharmaceuticals has recently added four independent directors with a wealth of knowledge and experience in various fields. The new additions include Dr Shailesh Ayyangar, Vijay Gokhale, Hitesh Jain and... Read More

Emcure Pharmaceuticals Ltd on Tuesday said that it has strengthened its board with the appointment of four independent directors. The move comes ahead of the company’s plans to file for... Read More

Kolkata, Jul 27(UNI) Emcure Pharmaceuticals Ltd, one of India’s leading pharma players continues to strengthen its leadership with the appointment of distinguished professionals to its board of directors. The company has... Read More

New Delhi, Jul 27 (PTI) Emcure Pharmaceuticals on Tuesday said it has strengthened its board with the inclusion of four new independent directors, including former Foreign Secretary Vijay Keshav Gokhale.... Read More

Cipla, Glenmark and Emcure significantly outperformed the market, with yoy growth of 19.9%, 38.8% and 24.9%, respectively. India Ratings and Research (Ind-Ra) opines the 14.1% yoy growth in India’s pharmaceutical market... Read More

In a significant development, Emcure Pharmaceuticals’ subsidiary Gennova Biopharmaceuticals Ltd is set to submit the data of Phase I trials for its mRNA vaccine candidate. This would be the first... Read More